Počet záznamů: 1  

Radiolabeling of antibody for epitope of human carbonic anhydrase IX (IgG M75) by 61Cu and 64Cu and its biological testing

  1. 1.
    SYSNO ASEP0450524
    Druh ASEPA - Abstrakt
    Zařazení RIVO - Ostatní
    NázevRadiolabeling of antibody for epitope of human carbonic anhydrase IX (IgG M75) by 61Cu and 64Cu and its biological testing
    Tvůrce(i) Čepa, Adam (UJF-V)
    Ráliš, Jan (UJF-V) SAI
    Pavelka, A. (CZ)
    Marešová, L. (CZ)
    Kleinová, M. (CZ)
    Seifert, Daniel (UJF-V) ORCID
    Sieglová, Irena (UMG-J)
    Král, Vlastimil (UMG-J) RID
    Polášek, Miloslav (UJF-V)
    Lebeda, Ondřej (UJF-V) RID, ORCID, SAI
    Paúrová, M. (CZ)
    Lázníček, M. (CZ)
    Celkový počet autorů12
    Zdroj.dok.European Journal of Nuclear Medicine and Molecular Imaging. - : Springer - ISSN 1619-7070
    Roč. 42, S (2015), s. 465-466
    Poč.str.2 s.
    Forma vydáníTištěná - P
    Akce28th Annual congress of the European-Association-of-Nuclear-Medicine (EANM)
    Datum konání10.10.2015-14.10.2015
    Místo konáníHamburg
    ZeměDE - Německo
    Typ akceEUR
    Jazyk dok.eng - angličtina
    Země vyd.US - Spojené státy americké
    Klíč. slovaantibodies ; Cu-61 ; Cu-64
    Vědní obor RIVBG - Jaderná, atomová a mol. fyzika, urychlovače
    Vědní obor RIV – spolupráceÚstav molekulární genetiky - Genetika a molekulární biologie
    CEPTA02010797 GA TA ČR - Technologická agentura ČR
    LM2011019 GA MŠMT - Ministerstvo školství, mládeže a tělovýchovy
    Institucionální podporaUJF-V - RVO:61389005 ; UMG-J - RVO:68378050
    UT WOS000363013202432
    AnotaceHuman carbonic anhydrase IX is a membrane enzyme that is significantly expressed in some types of cancer cells. The antibody IgG M75 was successfully conjugated with a new, copper-specific chelator “phosphinate”, the conjugation method was optimized and is well-reproducible. The conjugate was then labelled with two positron emitting copper radioisotopes, Cu-61 (3.333 h) and Cu-64 (12.701 h). Labelled conjugates were tested in vivo in mice with colorectal cancer xenografts. Copper radioisotopes were produced via Ni-nat(d,x) and Ni-64(p,n) reactions (Ni, 99.999 %, Goodfellow; Ni-64, 99.09 %, Isoflex). Specific activity of Cu-61 was 1 GBq/mg Cu and more, which was satisfactory for the labelling purposes. All reagents were analytical grade and were purified prior labelling with chelex-100 in sodium form, 100-200 mesh from metals surplus. Chelator “phospinate” was synthesized and characterized in our laboratories. Antibody IgG M75 was prepared by genetic engineering methods. Immunoconjugates (IgG M75-SCN-phospinate) were separated with use of PD 10 Desalting Columns and analyzed using size exclusion chromatography column BioSep SEC-S-3000. The conjugate M75-SCN-phosphinate was labelled successfully with both Cu-61 (96% yield) and Cu-64 (97% yield). Biodistribution experiments revealed high uptake of both labelled compounds in tumour tissue: Cu-61-labelled conjugate showed uptake of about 10 % ID/g after 6 hours, while Cu-64-labeled about 24 % ID/g even after 48 hours. The labelling resulted in the product of high specific activity (1.0 and 7.4 MBq/microgram, respectively) and of high radiochemical purity (> 95 %). The labelled molecule has considerable potential as a radioimmunopharmaceutical suitable for imaging of tumors expressing carbonic anhydrase IX by positron emission tomography.
    PracovištěÚstav jaderné fyziky
    KontaktMarkéta Sommerová, sommerova@ujf.cas.cz, Tel.: 266 173 228
    Rok sběru2016
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.